Premium
Idiosyncratic drug‐induced agranulocytosis: Possible mechanisms and management
Author(s) -
Tesfa Daniel,
Keisu Marianne,
Palmblad Jan
Publication year - 2009
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.21433
Subject(s) - neutropenia , drug , intensive care medicine , drug reaction , medicine , adverse effect , incidence (geometry) , immunology , pharmacology , chemotherapy , physics , optics
The incidence of drug‐induced neutropenia has not changed in the western hemisphere over the last 30 years. Yet, the drug panorama has changed considerably. This implies that host factors may play an intriguing role for this idiosyncratic reaction. The knowledge as to mechanisms for the reaction has advanced with emerging understanding of neutropoiesis and immune regulation. Nonetheless, it is still remarkably difficult to pinpoint why and how a drug causes this unexpected, severe adverse event in a patient. Patient characteristics, e.g. genetics, appear to be keys for better understanding, predictions and prevention. Am. J. Hematol. 2009. © 2009 Wiley‐Liss, Inc.